Rhea-AI Summary
Deutsche Bank has been appointed as the depositary bank for the American Depositary Receipt (ADR) program of Radiopharm Theranostics (OTC: RADTY). Radiopharm is a clinical stage radiotherapeutics company developing innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The company has been listed on ASX (RAD) since November 2021 and has a pipeline of distinct platform technologies spanning peptides, small molecules, and monoclonal antibodies for use in cancer treatment.
The ADR program details include:
- Country: Australia
- Custodian Bank: BNP Paribas S.A.
- Effective Date: September 18, 2024
- Level I ADR
- Symbol: RADTY
- Exchange: OTC
- Current Ratio: 1 ADS : 200 ordinary shares
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags